Business Acquisition (Tables)

12 Months Ended

Dec. 31, 2014

Business Combinations [Abstract]

Summary of Final Allocation of Purchase Consideration, Including Contingent Consideration Payable, Based on Fair Value

The following table presents the final allocation of the purchase consideration for the CureTech acquisition, including the contingent consideration payable, based on fair value.

Purchase consideration:
Cash	$	5,000
Acquisition-date fair value of contingent consideration		106,000
Total purchase consideration	$	111,000
Allocation of the purchase consideration:
Assets:
Identifiable intangible assets- IPR&D	$	101,000
Net identifiable assets acquired		101,000
Goodwill		10,000
Net assets acquired	$	111,000